High precision innovative micropump for artificial pancreas

被引:1
|
作者
Chappel, E. [1 ]
Mefti, S. [1 ]
Lettieri, G. -L. [1 ]
Proennecke, S. [1 ]
Conan, C. [1 ]
机构
[1] Debiotech SA, CH-1004 Lausanne, Switzerland
来源
MICROFLUIDICS, BIOMEMS, AND MEDICAL MICROSYSTEMS XII | 2014年 / 8976卷
关键词
MEMS; Micropump; artificial pancreas; closed-loop system; insulin delivery; SUBCUTANEOUS INSULIN INFUSION; INJECTIONS;
D O I
10.1117/12.2036068
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The concept of artificial pancreas, which comprises an insulin pump, a continuous glucose meter and a control algorithm, is a major step forward in managing patient with type 1 diabetes mellitus. The stability of the control algorithm is based on short-term precision micropump to deliver rapid-acting insulin and to specific integrated sensors able to monitor any failure leading to a loss of accuracy. Debiotech's MEMS micropump, based on the membrane pump principle, is made of a stack of 3 silicon wafers. The pumping chamber comprises a pillar check-valve at the inlet, a pumping membrane which is actuated against stop limiters by a piezo cantilever, an anti-free-flow outlet valve and a pressure sensor. The micropump inlet is tightly connected to the insulin reservoir while the outlet is in direct communication with the patient skin via a cannula. To meet the requirement of a pump dedicated to closed-loop application for diabetes care, in addition to the well-controlled displacement of the pumping membrane, the high precision of the micropump is based on specific actuation profiles that balance effect of pump elasticity in low-consumption push-pull mode.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Coming of age: the artificial pancreas for type 1 diabetes
    Hood Thabit
    Roman Hovorka
    Diabetologia, 2016, 59 : 1795 - 1805
  • [22] Automated Insulin Delivery: The Artificial Pancreas Technical Challenges
    Hernando, M. Elena
    Garcia-Saez, Gema
    Gomez, Enrique J.
    Perez-Gandia, Carmen
    Rodriguez-Herrero, Agustin
    AMERICAN JOURNAL OF THERAPEUTICS, 2020, 27 (01) : E62 - E70
  • [23] What is the current state of the artificial pancreas in diabetes care?
    Dimou, M.
    Laimer, M.
    Stettler, C.
    Bally, L.
    INTERNIST, 2020, 61 (01): : 102 - 109
  • [24] Coming of age: the artificial pancreas for type 1 diabetes
    Thabit, Hood
    Hovorka, Roman
    DIABETOLOGIA, 2016, 59 (09) : 1795 - 1805
  • [25] A generic telemedicine infrastructure for monitoring an artificial pancreas trial
    Capozzi, Davide
    Lanzola, Giordano
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2013, 110 (03) : 343 - 353
  • [26] Innovative High-Precision Position Sensor Systems for Robotic and Automotive Applications
    Kirchhoff, M. R.
    Boese, C.
    Guettler, J.
    Feldmann, M.
    Buettgenbach, S.
    PROCEEDINGS OF THE EUROSENSORS XXIII CONFERENCE, 2009, 1 (01): : 501 - 504
  • [27] The Artificial Pancreas: A Dynamic Challenge
    Stavdahl, Oyvind
    Fougner, Anders L.
    Kolle, Konstanze
    Christiansen, Sverre Chr.
    Ellingsen, Reinold
    Carlsen, Sven M.
    IFAC PAPERSONLINE, 2016, 49 (07): : 765 - 772
  • [28] Artificial Pancreas in Young Children
    Ohman-Hanson, Rebecca A.
    Forlenza, Gregory P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (05) : 277 - 279
  • [29] Distributed Aspects of the Artificial Pancreas
    Patek, Stephen D.
    Chen, Sanjian
    Keith-Hynes, Patrick
    Lee, Insup
    2013 51ST ANNUAL ALLERTON CONFERENCE ON COMMUNICATION, CONTROL, AND COMPUTING (ALLERTON), 2013, : 543 - 550
  • [30] The role of glucagon in the artificial pancreas
    Haidar, Ahmad
    Smaoui, Mohamed Raef
    Legault, Laurent
    Rabasa-Lhoret, Remi
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (06) : 476 - 479